Viz.ai announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease at the 48th annual VEITHsymposium from November 16–20, 2021 in Orlando, Florida.
Viz.ai is the only artificial intelligence company with modules for the detection of suspected pulmonary embolism and aortic disease.
The platform gives you access to high fidelity imaging for suspected PE or AD patients and helps catalyze care with one-click team activation.
Schedule a virtual demo to see how we can help streamline your vascular response workflow.
